Collaborative Drug Discovery

This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages) This article contains content that is written like an advertisement. Please help improve it by removing promotional content and inappropriate external links, and by adding encyclopedic content written from a neutral point of view. (December 2022) (Learn how and when to remove this message) This article relies excessively on references to primary sources. Please improve this article by adding secondary or tertiary sources. Find sources: "Collaborative Drug Discovery" – news · newspapers · books · scholar · JSTOR (December 2022) (Learn how and when to remove this message) (Learn how and when to remove this message)

Collaborative Drug Discovery, Inc.

Company type	Private
Industry	Life Sciences Informatics ELN Pharma Intelligence
Founded	2004; 20 years ago (2004)
Headquarters	Burlingame, California, U.S.
Products	CDD Vault PharmaKB CDD Public
Website	collaborativedrug.com

Collaborative Drug Discovery (CDD) is a software company founded in 2004 as a spin-out of Eli Lilly by Barry Bunin, PhD. CDD utilizes a web-based database solution for managing drug discovery data, primarily through the CDD Vault product which is focused around small molecules and associated bio-assay data. In 2021, CDD launched its first commercial data offering, PharmaKB,^[1] formerly BioHarmony,^[2][3] as The Pharma KnowledgeBase, which is centered around pharma company, drug, and disease information for research, business intelligence, and investors.